Variables | n | Death | Univariate analysis | p-value | Multivariate model | p-value |
Age (ans) |
|
|
| 0.0109* |
| 0.0666 |
<60 | 22 | 36.4% (8/22) |
|
| - |
|
≥60 | 21 | 76.2% (16/21) | 5.6 [1.56 - 22.9] |
| 2.8 [1.14 - 19.3] |
|
Gender |
|
|
| 0.4431 |
|
|
Female | 9 | 44.4% (4/9) | - |
| - |
|
Male | 34 | 58.8% (20/34) | 1.7 [0.4 - 8.3] |
| - |
|
Comorbidities |
|
|
|
|
|
|
Hypertension | 25 | 56% (14/25) | 1.0 [0.3 - 3.4] | 0.9 |
|
|
Diabetes | 15 | 46.7% (7/15) | 0.5 [0.1 - 2] | 0.3787 |
|
|
Clinical signs |
|
|
|
|
|
|
Hypotension | 1 | 0 | - | 0.4418 |
|
|
Fever | 7 | 85.7% (6/7) | 6.8 [1 - 137] | 0.09 |
|
|
Respiratory distress | 26 | 73.1% (19/26) | 19 [2.7 - 39] | 0.01* | 1.36 [1.5 - 3.8] | 0.7917 |
Biological signs |
|
|
|
|
|
|
Haemoglobin < 12 g/dl | 16 | 62.5% (10/16) | 1.5 [0.4 - 5.7] | 0.4978 |
|
|
Hyperkalemia | 12 | 75% (9/12) | 3 [0.7 - 15.7] | 0.1517 |
|
|
Uremia (g/l) |
|
|
| 0.4332 |
|
|
<2 | 22 | 50% (11/22) | - |
|
|
|
≥2 | 21 | 61.9% (13/21) | 1.6 [0.4 - 5.6] | 0.4332 |
|
|
CRP (mg/l) |
|
|
|
|
|
|
<30 | 4 | ¼ (25%) | - |
|
|
|
[30 - 60[ | 8 | 3/8 (37.5%) | 1.8 [0.1 - 46.2] | 0.6670 |
|
|
≥60 | 27 | 19/27 (70.4%) | 7.1 [0.7 - 156.8] | 0.1102 |
|
|
CT lesions |
|
|
|
|
|
|
Interstitial | 42 | 57.1% (24/42) | + | 0.9944 |
|
|
Alveolar | 30 | 63.3% (19/30) | 2.8 [0.7 - 11.2] | 0.1375 |
|
|
Pleurisy | 20 | 55% (11/20) | 0.9 [0.3 - 3.1] | 0.9202 |
|
|
KDIGO stage |
|
|
| 0.04964 |
|
|
1 | 9 | 77.8% (7/9) | - |
| - |
|
2 | 9 | 22.2% (2/9) | 0.08 [0 - 0.6] |
| 0.14 [0 - 0.1] | 0.0148* |
3 | 25 | 60% (15/25) | 0.4 [1.1 - 2.2] |
| 0.7 [0 - 0.1] | 0.0492* |
Type of kidney involvement |
|
|
| 0.5374 |
|
|
FKI | 14 | 42.8% (6/14) | - |
|
|
|
NTA | 10 | 60% (6/10) | 2.2 [0.6 - 9.8] |
|
|
|
Not determined | 19 | 63.2% (12/19) | 2 [0.3 - 11.1] |
|
|
|
Duration of the disease |
|
|
| 0.5953 |
|
|
<7 days | 6 | 66.7% (4/6) | - |
|
|
|
≥7 days | 37 | 54.1% (20/37) | 0.6 [0.1 - 3.4] |
|
|
|
Treatment |
|
|
|
|
|
|
Antibiotics | 40 | 52.5% (21/40) | - | 0.2425 |
|
|
Anticoagulants | 28 | 60.7% (17/28) | 1.7 [0.4 - 6] | 0.3787 |
|
|
Corticosteroids | 28 | 53.6% (15/28) | 0.7 [0.2 - 2.7] | 0.6861 |
|
|
Vasoactive amines | 15 | 86.7% (13/15) | 10 [2.2 - 72.7] | 0.0068* | 0.6 [0.2 - 3.9] | 0.2975 |
Invasive ventilation | 19 | 89.5% (17/19) | 20 [4.4 - 154.7] | <0.001* | 22.5 [8.7 - 207.7] | 0.0120* |
Hemodialysis | 21 | 52.4% (11/21) | 0.7 [0.2 - 2.5] | 0.6581 |
|
|